Skip to main content
| News

Basel Area life sciences cluster will be further strengthened

05.11.2020

The global nutrition and health corporation Royal DSM is establishing a new innovation center at the headquarters of Nutritional Products in Kaiseraugst. The Nutrition & Health Campus will be ready in 2023. This gives the Basel Area life sciences cluster a further boost.

The new Nutrition & Health Campus of DSM (Visualization: Nissen Wentzlaff Architekten)

Royal DSM is creating its new Health & Nutrition Campus on the site of Nutritional Products in Kaiseraugst. It will encompass modern research laboratories and collaborative workplaces. Construction is set to begin at the start of 2021 and the building will be ready for use in 2023.

The Campus will bring together more than 200 researchers from the fields of chemicals, formulation, application and analytics. According to a press release, this unites the research & development department with all other innovation activities and business functions to create “the company’s largest global innovation hub”.

When compared with the current situation, which sees employees split across three different buildings, energy consumption for heating will be reduced by 90 percent and electricity use by 80 percent. Transparent bridges will connect the new building and the main existing Nutritional Products global headquarters building. Local landscape designers will be creating a near-natural environment, which will “significantly enhance” the green spaces and biodiversity. The plan is also to incorporate a fully-equipped fitness center for all staff. The campus concept was put together by the Basel office of Nissen Wentzlaff Architekten.

“Our aim is to create a new center of gravity for innovation in the area of nutrition and health, and further strengthen the region in its significance,” commented Thomas Beck, Senior Vice President Innovation. With the construction of the DSM innovation center, the importance of the Basel Area life sciences cluster in particular continues to grow.

The global DSM Nutritional Products Business Group is run out of Kaiseraugst. Local production facilities include manufacturing plants in in Aesch BL, Sisseln AG, Lalden/Visp VS as well as in Baden-Württemberg and in the Alsatian Village-Neuf in the immediate vicinity of Basel.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

Gamma Technologies acquires ProFEMAG portfolio
Advanced Manufacturing/AI, Basel Area Business & Innovation, ICT, Innovation, Invest

Gamma Technologies acquires ProFEMAG portfolio

The Basel-based firm ProFEMAG AG has sold its FEMAG software for electrical machine applications to Gamma Technologies. The company based...

Read More
Databaum establishes headquarters in Basel
Basel Area Business & Innovation, ICT, Innovation, Invest, Life Sciences / biotech

Databaum establishes headquarters in Basel

Databaum is establishing its headquarters in Basel and plans to grow from its location there. The startup provides the agricultural...

Read More
Clinerion launches patient information platform
Basel Area Business & Innovation, Digital Health, ICT, Innovation, Invest, Life Sciences / biotech

Clinerion launches patient information platform

Basel-based Clinerion is introducing its machine learning platform. It comprises a global network of hospitals and enables researchers to recognize...

Read More
New innovation campus opens in the Basel Area
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech, Switzerland Innovation Park

New innovation campus opens in the Basel Area

The Main Campus of the Switzerland Innovation Park Basel Area was officially opened on October 29. In his speech, Federal...

Read More
Sumitovant acquires all shares in Myovant
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Sumitovant acquires all shares in Myovant

Sumitovant is in the process of making Basel-based Myovant Sciences a wholly owned subsidiary by acquiring a 100 percent shareholding...

Read More
VectivBio raises 125 million US dollars in stock sale
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

VectivBio raises 125 million US dollars in stock sale

VectivBio has announced the closing of the subscription offer for 16,700,000 ordinary shares. The Basel-based biotechnology firm has generated gross...

Read More
1 2 3 29

Do you have a question? We'd like to hear from you.